Medtronic (NYSE: MDT) plans to spin off its patient-monitoring and respiratory intervention businesses into a new company.
The two businesses together account for about $2.2 billion in annual revenue, or about 7% of Medtronic's total revenue of $31.7 billion, and about 8,000 employees — a relatively small number of those in Minnesota, according to a spokesperson.
The Patient Monitoring group includes business lines such as Nellcor pulse oximetry products, a brain-monitoring system called BIS…
